Trial Details
COMPLETEDBasic Information
| Clinical ID | c2279 |
|---|---|
| Identifier | NCT03750565 |
| Trial Title | Multiple Dose Ethnobridging PK Study in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|IBD |
| Interventions | DRUG: TD-1473 - Dose A|DRUG: TD-1473 - Dose B|DRUG: TD-1473 - Dose C|DRUG: Placebo |
Participant Information
| Sponsor | Theravance Biopharma |
|---|---|
| City | Cypress |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-11-27 |
|---|---|
| Primary Completion Date | 2019-02-13 |
| Completion Date | 2019-02-13 |